Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins

被引:25
|
作者
Liu, Yalan [1 ]
Luo, Sukun [1 ,2 ]
He, Siyi [1 ,2 ]
Zhang, Mudan [1 ,2 ]
Wang, Ping [1 ,2 ]
Li, Chang [1 ,2 ]
Huang, Wenjie [1 ]
Hu, Bodan [1 ,2 ]
Griffin, George E. [3 ]
Shattock, Robin J. [4 ]
Hu, Qinxue [1 ,3 ]
机构
[1] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England
[4] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Fac Med, London W2 1PG, England
基金
中国国家自然科学基金;
关键词
HSV-2; Tetherin; Viral release; Viral glycoprotein; HERPES-SIMPLEX-VIRUS; DOWN-REGULATION; HIV-1; RELEASE; CELL-SURFACE; PROTEIN; EXPRESSION; INFECTION; VPU; COMPLEX; TYPE-1;
D O I
10.1016/j.virol.2014.11.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tetherin has been defined as a restriction factor of HIV-1 and several other enveloped viruses. However, the significance of tetherin in viral infection remains to be further addressed. Here, we investigated whether tetherin plays a role in HSV-2 infection. Our study revealed that overexpression of tetherin restricted the release of HSV-2 into the extracellular medium, while knockdown of tetherin by siRNA enhanced its release. We further demonstrated that HSV-2 infection and viral glycoproteins gB, gD, gH and gL but not gM significantly downregulated the endogenous expression of tetherin. Additional study indicated that tetherin likely physically interacted with gB, gD, gH and gL. This is the first time that tetherin has been shown to be counteracted by multiple viral components of a virus. Our findings inform the complexity of HSV-2-host interactions, providing basis for understanding the role of tetherin as a viral restriction factor and the mechanisms underlying viral countermeasures. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 109
页数:14
相关论文
共 50 条
  • [2] Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists
    Hagelauer, Elena
    Lotke, Rishikesh
    Kmiec, Dorota
    Hu, Dan
    Hohner, Mirjam
    Stopper, Sophie
    Nchioua, Rayhane
    Kirchhoff, Frank
    Sauter, Daniel
    Schindler, Michael
    VIRUSES-BASEL, 2023, 15 (12):
  • [3] HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway
    Liu, Yalan
    Li, Mei
    Zhang, Di
    Zhang, Mudan
    Hu, Qinxue
    VIROLOGY JOURNAL, 2016, 13
  • [4] HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway
    Yalan Liu
    Mei Li
    Di Zhang
    Mudan Zhang
    Qinxue Hu
    Virology Journal, 13
  • [5] Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge
    Heineman, TC
    Pesnicak, L
    Ali, MA
    Krogmann, T
    Krudwig, N
    Cohen, JI
    VACCINE, 2004, 22 (20) : 2558 - 2565
  • [6] Stabilization of HSV-2 viral vaccine candidate by spray drying
    LeClair, Daniel A.
    Li, Lillian
    Rahman, Nausheen
    Cranston, Emily D.
    Xing, Zhou
    Thompson, Michael R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
  • [7] Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein
    Zadeh, Vahid Rajabali
    Urata, Shuzo
    Sakaguchi, Miako
    Yasuda, Jiro
    JOURNAL OF GENERAL VIROLOGY, 2020, 101 (06): : 573 - 586
  • [8] Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology
    Bergstrom, T
    Trybala, E
    INTERVIROLOGY, 1996, 39 (03) : 176 - 184
  • [9] VIRAL OVERLOAD: HSV-2 MENINGITIS IN A PATIENT WITH HIV AND DISSEMINATED MONKEYPOX
    Kale, Neel
    Pope, Helen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S563 - S564
  • [10] Cutaneous HSV-2 infection with serial recurrences at multiple sites
    Dacko, A
    Don, PC
    Weinberg, JM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (02) : 109 - 111